FDA Approved: BRIVARACETAM — Supplemental Application (SolarisPharmaCorporation)

View source ↗

Summary

The FDA approved a supplemental application for brivaracetam from SolarisPharmaCorporation, signaling regulatory action to update the drug's authorization (pote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

SUPPL AP for BRIVARACETAM (BRIVARACETAM)